Bolstering its market presence and catering for growing demand from pet health conscious owners, Universal Biosensors (ASX: UBI) has secured partnerships with five new distribution partners for its Petrackr product. Petrackr is a biosensor tech product developed by Universal Biosensors, designed to monitor and track the level of blood glucose in real-time. These biomarkers hold
Read MoreIn the land of sugar and fat, health concerns for the general population are rising and this has extended towards our furry friends where diabetes in cats and dogs are a real risk which is being addressed by biotech company Universal Biosensors (ASX: UBI) and their blood sugar monitoring device. As the latest extension of
Read MoreA handheld device which can remotely diagnose the presence of cancer cells is on the horizon with biotech company Universal Biosensors (ASX: UBI) partnering with the Peter MacCallum Cancer Centre on the project. Under the agreement, Peter Mac will supply cancer patient samples to Universal Biosensors which will use the plasma samples in their trials
Read MoreLife expectancy rates following the diagnosis of cancer could soon be significantly improved through early detection if biotech company Universal Biosensors (ASX: UBI) is successful in their newest research collaboration aiming to instantly identify cancer cells from a simple finger prick. The research project will be part of an exclusive collaboration between Deakin University’s Institute
Read MoreThe art of winemaking is getting ever more scientific and this will be accelerated in the United States with Universal Biosensors (ASX: UBI) hand-held element tester to commence distribution through the American wine industry. The Sentia™ Analyzer is a handheld device that enables winemakers to test various levels of acidity and sugars in their wine
Read MoreThe content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.